A Study To Evaluate Escalating Doses of A Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
Conditions: Non-Small Cell Lung Cancer; Triple-negative Breast Cancer Intervention: Biological: PF-06936308 Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Immunotherapy | Non-Small Cell Lung Cancer | Pfizer | Study | Vaccines